Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
3 Steps to Set Your Course Book a Discovery Call
We offer structured maintenance programs that may include continued GLP-1 support (when appropriate), other medications and supplements, wellness services such as B12 and Glutathione, and coaching
Consequently, further investigation is warranted [29]
Long-Term effectiveness and outcomes of bariatric surgery: A comprehensive review of current evidence and emerging trends
The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model